Duration of non-insulin-dependent diabetes mellitus and the TNF-β NcoI genotype as predictive factors in proliferative diabetic retinopathy

Ophthalmologica

Volumn 215, Issue 4, 2001, Pages 294-298

  Kaňková, Kateřina ^a   Mužík, Jan ^a   Karásková, Jana ^b   Beránek, Michal ^a   Hájek, Dobroslav ^a   Znojil, Vladimír ^a   Vlková, Eva ^b   Vácha, Jiří ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Angiotensin converting enzyme; Endothelin 1; Non insulin dependent diabetes mellitus; Proliferative diabetic retinopathy; Tumor necrosis factor

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; LYMPHOTOXIN;

ADULT; AGED; ALLELISM; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

ALLELES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DNA PRIMERS; ENDOTHELIN-1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TIME FACTORS;

EID: 0034956879     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050877     Document Type: Article

References (22)

1. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
4. Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics
5. Diabetic retinopathy in identical twins
6. Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 years of age
7. Angiotensin levels in the eye
8. Elevated serum levels of angiotensin-converting enzyme in patients with diabetic retinopathy
9. Serum angiotensin converting enzyme in diabetic patients
10. Serum angiotensin converting enzyme in diabetic retinopathy
11. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)
12. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk
13. Increased plasma endothelin in NIDDM patients with retinopathy
14. Increased levels of plasma endothelin-1 in non-insulin dependent diabetic patients with retinopathy but without other diabetes-related organ damage
15. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients
16. Endothelin: Emerging role in diabetic vascular complications
17. Cytokines in human intraocular inflammation
18. Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy
19. An association in non-insulin-dependent diabetes mellitus subjects between susceptibility to retinopathy and tumor necrosis factor polymorphism
20. Grading diabetic retinopathy from stereoscopic color fundus photographs - An extension of the modified Airlie House classification
21. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis
22. Cytokines in the vitreous of patients with proliferative diabetic retinopathy